[go: up one dir, main page]

AR120117A2 - PD-1 BINDING MOLECULES AND METHODS OF USE THEREOF - Google Patents

PD-1 BINDING MOLECULES AND METHODS OF USE THEREOF

Info

Publication number
AR120117A2
AR120117A2 ARP200102705A ARP200102705A AR120117A2 AR 120117 A2 AR120117 A2 AR 120117A2 AR P200102705 A ARP200102705 A AR P200102705A AR P200102705 A ARP200102705 A AR P200102705A AR 120117 A2 AR120117 A2 AR 120117A2
Authority
AR
Argentina
Prior art keywords
mab
binding
antibodies
methods
present
Prior art date
Application number
ARP200102705A
Other languages
Spanish (es)
Inventor
Kalpana Shah
Douglas H Smith
Motte-Mohs Ross La
Leslie S Johnson
Paul A Moore
Ezio Bonvini
Scott Koenig
Original Assignee
Macrogenics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Macrogenics Inc filed Critical Macrogenics Inc
Publication of AR120117A2 publication Critical patent/AR120117A2/en

Links

Landscapes

  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

Abstract

La presente se dirige a anticuerpos antiPD-1 seleccionados capaces de unirse tanto a PD-1 de mono cynomolgus y a PD-1 de humano: mAb 1 de PD-1, mAb 2 de PD-1, mAb 3 de PD-1, mAb 4 de PD-1, mAb 5 de PD-1, mAb 6 de PD-1, mAb 7 de PD-1, mAb 8 de PD-1, mAb 9 de PD-1, mAb 10 de PD-1, mAb 11 de PD-1, mAb 12 de PD-1, mAb 13 de PD-1, mAb 14 de PD-1 o mAb 15 de PD-1, y a versiones humanizadas o quiméricas de tales anticuerpos. La presente pertenece de manera adicional a moléculas de unión a PD-1 que comprenden fragmentos de unión a PD-1 de tales anticuerpos anti-PD-1, inmunoconjugados, y a moléculas biespecíficas, que incluyen diacuerpos, BiTE, anticuerpos biespecíficos, etc., que comprenden (i) tales fragmentos de unión a PD-1, y (ii) un dominio capaz de unir un epítopo de una molécula involucrada en regular un punto de control inmune presente en la superficie de células inmunes. La presente también pertenece a métodos para utilizar moléculas que se unen a PD-1 para estimular respuestas inmunes, así como a métodos para detectar PD-1.This is directed to selected anti-PD-1 antibodies capable of binding to both cynomolgus monkey PD-1 and human PD-1: PD-1 mAb 1, PD-1 mAb 2, PD-1 mAb 3, mAb PD-1 mAb 4, PD-1 mAb 5, PD-1 mAb 6, PD-1 mAb 7, PD-1 mAb 8, PD-1 mAb 9, PD-1 mAb 10, mAb 11 PD-1 mAb, PD-1 mAb 12, PD-1 mAb 13, PD-1 mAb 14 or PD-1 mAb 15, and humanized or chimeric versions of such antibodies. The present invention further pertains to PD-1 binding molecules comprising PD-1 binding fragments of such anti-PD-1 antibodies, immunoconjugates, and to bispecific molecules, including diabodies, BiTE, bispecific antibodies, etc., comprising (i) such PD-1 binding fragments, and (ii) a domain capable of binding an epitope of a molecule involved in regulating an immune checkpoint present on the surface of immune cells. The present invention also pertains to methods of using PD-1 binding molecules to stimulate immune responses, as well as methods of detecting PD-1.

ARP200102705A 2015-07-30 2020-09-29 PD-1 BINDING MOLECULES AND METHODS OF USE THEREOF AR120117A2 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US201562198867P 2015-07-30 2015-07-30

Publications (1)

Publication Number Publication Date
AR120117A2 true AR120117A2 (en) 2022-02-02

Family

ID=60244687

Family Applications (2)

Application Number Title Priority Date Filing Date
ARP160102301A AR105520A1 (en) 2015-07-30 2016-07-28 PD-1 BINDING MOLECULES AND SAME USE METHODS
ARP200102705A AR120117A2 (en) 2015-07-30 2020-09-29 PD-1 BINDING MOLECULES AND METHODS OF USE THEREOF

Family Applications Before (1)

Application Number Title Priority Date Filing Date
ARP160102301A AR105520A1 (en) 2015-07-30 2016-07-28 PD-1 BINDING MOLECULES AND SAME USE METHODS

Country Status (2)

Country Link
AR (2) AR105520A1 (en)
MA (1) MA47137B1 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA3104778A1 (en) * 2018-07-11 2020-01-16 Kahr Medical Ltd. Pd1-4-1bbl variant fusion protein and methods of use thereof
CN116854820B (en) * 2023-06-26 2024-02-06 华中科技大学同济医学院附属协和医院 PD-1 non-blocking scavenging antibodies and their uses

Also Published As

Publication number Publication date
AR105520A1 (en) 2017-10-11
MA47137A (en) 2019-10-30
MA47137B1 (en) 2021-08-31

Similar Documents

Publication Publication Date Title
MX2022014645A (en) MOLECULES BINDING TO PD-1 AND METHODS OF USE THEREOF.
ECSP17080639A (en) LAG-3 BINDING MOLECULES AND METHODS OF USING THEM
ECSP18043564A (en) BI-SPECIFIC MOLECULES THAT HAVE IMMUNOREACTIVITY WITH PD-1 AND CTLA-4, AND METHODS OF USE OF THE SAME
MX2024001803A (en) ANTI-TREM2 ANTIBODIES AND METHODS OF USING THEM.
PE20200486A1 (en) ANTI-CD33 ANTIBODIES AND METHODS OF USING THEM
MX2020004503A (en) HUMANIZED OR CHIMERIC CD3 ANTIBODIES.
MX2017012802A (en) ANTISORTILINE ANTIBODIES AND METHODS FOR USE.
AR120117A2 (en) PD-1 BINDING MOLECULES AND METHODS OF USE THEREOF
AR104919A1 (en) LAG-3 BINDING MOLECULES AND SAME USE METHODS
MY188871A (en) Pd-1-binding molecules and methods of use thereof
EA202090579A1 (en) PD-1-BINDING MOLECULES AND METHODS OF THEIR APPLICATION
NZ778490A (en) Pd-1-binding molecules and methods of use thereof